Cargando…
Medicines for Malaria Venture COVID Box: a source for repurposing drugs with antifungal activity against human pathogenic fungi
BACKGROUND: Treatment of mycoses is often ineffective, usually prolonged, and has some side effects. These facts highlight the importance of discovering new molecules to treat fungal infections. OBJECTIVES: To search the Medicines for Malaria Venture COVID Box for drugs with antifungal activity. MET...
Autores principales: | Almeida-Paes, Rodrigo, de Andrade, Iara Bastos, Ramos, Mariana Lucy Mesquita, Rodrigues, Marcus Vinícius de Araújo, do Nascimento, Vinícius Alves, Bernardes-Engemann, Andréa Reis, Frases, Susana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Instituto Oswaldo Cruz, Ministério da Saúde
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577065/ https://www.ncbi.nlm.nih.gov/pubmed/34755820 http://dx.doi.org/10.1590/0074-02760210207 |
Ejemplares similares
-
Clinical Challenges of Emerging and Re-Emerging Yeast Infections in the Context of the COVID-19 Pandemic
por: Corrêa-Junior, Dario, et al.
Publicado: (2022) -
Novel Antifungal Compounds Discovered in Medicines for Malaria Venture’s Malaria Box
por: Jung, Eric H., et al.
Publicado: (2018) -
Screening a repurposing library, the Medicines for Malaria Venture Stasis Box, against Schistosoma mansoni
por: Pasche, Valérian, et al.
Publicado: (2018) -
Identification of Anti-staphylococcal and Anti-biofilm Compounds by Repurposing the Medicines for Malaria Venture Pathogen Box
por: Bhandari, Vasundhra, et al.
Publicado: (2018) -
Assessing the In Vitro Potential of Glatiramer Acetate (Copaxone(®)) as a Chemotherapeutic Candidate for the Treatment of Cryptococcus neoformans Infection
por: Alves, Vinicius, et al.
Publicado: (2023)